Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04284228
Title Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NexImmune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Advent Health Medical Group Blood & Marrow Transplant Orlando Florida 32804 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
The James Cancer Hospital and Solove Research Institute OSUCC Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field